Abstract
Recent studies have suggested that B7-CD28 interactions provide co-stimulatory signals for activation of NK cells. Transduction of the B7.1 (CD80) gene into tumor cells has been shown to trigger proliferation and cytotoxicity of murine NK cells and a human NK cell line, YT2C2. Therefore, transduction of the B7.1 gene into CD80-negative human squamous cell carcinomas of the head and neck (SCCHN) and its stable expression was expected to upregulate proliferation and cytotoxic activities of human NK cells. However, expression of the B7.1 receptors, CD28 and CTLA-4, could not be demonstrated on the surface or in the cytoplasm of normal human NK cells, irrespective of the state of their activation. In proliferation experiments or various cytotoxicity assays, utilizing highly purified human NK cells as responder or effector cells, no enhancement of NK cell generation or activity, respectively, by B7.1+ SCCHN was observed relative to non-transduced or LacZ gene-transduced SCCHN. In contrast, co-incubation of B7.1+ SCCHN targets with human NK cells induced significant inhibition of NK cell growth. Thus, the B7.1-CD28/CTLA-4 pathway is not involved in triggering of human adult NK cells.
References
Sep 1, 1991·The Journal of Experimental Medicine·P S LinsleyJ A Ledbetter
Apr 1, 1988·Proceedings of the National Academy of Sciences of the United States of America·G P NolanL A Herzenberg
Sep 11, 1970·Science·P Bretscher, M Cohn
Jan 1, 1981·Journal of Clinical Immunology·H F ProssM S Patterson
Jul 1, 1994·Immunology Today·C H JuneC B Thompson
Jan 1, 1995·Cellular Immunology·A H MontelZ Brahmi
May 1, 1995·European Journal of Immunology·F CavalloG Casorati
Oct 15, 1995·Cellular Immunology·K Y YehE M Lord
Nov 1, 1995·The Journal of Experimental Medicine·T C WuD M Pardoll
Jan 15, 1993·Science·S E Townsend, J P Allison
Jun 1, 1993·The Journal of Experimental Medicine·F A Harding, J P Allison
Oct 1, 1993·Cellular Immunology·N L VujanovicT L Whiteside
Feb 25, 1996·Cellular Immunology·R RogerJ Bertoglio
Jun 1, 1996·European Journal of Immunology·L ZitvogelM T Lotze
Oct 1, 1996·Immunity·B J ChambersH G Ljunggren
Feb 1, 1997·Immunological Reviews·A MorettaL Moretta
Citations
Dec 26, 2001·Molecular Immunology·Raquel TarazonaRafael Solana
Apr 4, 2006·Nature Immunology·Jadee L UpshawPaul J Leibson
Nov 5, 2002·Nature Reviews. Cancer·Mark J SmythHideo Yagita
Mar 10, 2005·Blood·Chihaya ImaiDario Campana
Apr 15, 1999·Nature Medicine·N C FernandezL Zitvogel
Mar 3, 2018·Frontiers in Immunology·Rohtesh S Mehta, Katayoun Rezvani
Apr 1, 2017·Experimental & Molecular Medicine·Hyung-Joon KwonHun Sik Kim
Sep 7, 2018·European Journal of Haematology·Katharina KriegsmannMathias Witzens-Harig
Jan 31, 2020·Frontiers in Immunology·Pilar M LanuzaJulian Pardo
Apr 2, 2014·The Journal of Immunology : Official Journal of the American Association of Immunologists·Ana StojanovicAdelheid Cerwenka
Dec 24, 2015·Nature Reviews. Cancer·Maelig G Morvan, Lewis L Lanier
Sep 15, 2017·Journal of Oral Science·Alison MarshallStephen Porter
Mar 22, 2019·Archives of Pharmacal Research·Nayoung KimHun Sik Kim
Mar 21, 2020·Cancers·Aline Pfefferle, Nicholas D Huntington
Sep 27, 2018·Frontiers in Immunology·Nayoung Kim, Hun Sik Kim
Mar 3, 2020·Frontiers in Immunology·Muhammad KhanHua Wang
Jul 10, 2020·Cancers·Sachin Kumar Singh ChauhanStephan Kloess
Jan 23, 2020·HNO·N Ludwig, M T Lotze
May 21, 2020·International Journal of Molecular Sciences·Nico M SieversNiels Schaft
Oct 5, 2018·Cancer Immunology Research·Fernando Concha-BenaventeRobert L Ferris
Feb 13, 2021·Cancers·Elisa C ToffoliTanja D de Gruijl
Dec 6, 2020·Cancer Discovery·May Daher, Katayoun Rezvani
Feb 7, 2021·Cancers·Martina MolgoraMarco Colonna
May 3, 2002·Clinical and Diagnostic Laboratory Immunology·D HallerS Blum
Aug 12, 2021·Genome Medicine·Emily F Davis-MarcisakElana J Fertig
Jan 25, 2019·Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation·Larisa ShelikhovaMichael Maschan